Form 8-K - Current report:
SEC Accession No. 0001104659-21-020705
Filing Date
2021-02-11
Accepted
2021-02-11 16:15:27
Documents
2
Period of Report
2021-02-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm216262d1_8k.htm 8-K 17914
2 EXHIBIT 99.1 tm216262d1_ex99-1.htm EX-99.1 16902
  Complete submission text file 0001104659-21-020705.txt   36200
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 21619847
SIC: 2834 Pharmaceutical Preparations